Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
Structural Bioinformatics Laboratory, Biochemistry, Faculty of Science and Engineering, Åbo Akademi University, Turku, Finland.
Eur J Pharm Sci. 2019 Sep 1;137:104963. doi: 10.1016/j.ejps.2019.104963. Epub 2019 Jun 18.
Transport proteins of the ATP-binding cassette (ABC) family are found in all kingdoms of life. In humans, several ABC efflux transporters play a role in drug disposition and excretion. Therefore, in vitro methods have been developed to characterize the substrate and inhibitor properties of drugs with respect to these transporters. In the vesicular transport assay, transport is studied using inverted membrane vesicles produced from transporter overexpressing cell lines of both mammalian and insect origin. Insect cell expression systems benefit from a higher expression compared to background, but are not as well characterized as their mammalian counterparts regarding endogenous transport. Therefore, the contribution of this transport in the assay might be underappreciated. In this study, endogenous transport in membrane vesicles from Spodoptera frugiperda -derived Sf9 cells was characterized using four typical substrates of human ABC transporters: 5(6)-carboxy-2,'7'-dichlorofluorescein (CDCF), estradiol-17β-glucuronide, estrone sulfate and N-methyl-quinidine. Significant ATP-dependent transport was observed for three of the substrates with cholesterol-loading of the vesicles, which is sometimes used to improve the activity of human transporters expressed in Sf9 cells. The highest effect of cholesterol was on CDCF transport, and this transport in the cholesterol-loaded Sf9 vesicles was time and concentration dependent with a K of 8.06 ± 1.11 μM. The observed CDCF transport was inhibited by known inhibitors of human ABCC transporters, but not by ABCB1 and ABCG2 inhibitors verapamil and Ko143, respectively. Two candidate genes for ABCC-type transporters in the S. frugiperda genome (SfABCC2 and SfABCC3) were identified based on sequence analysis as a hypothesis to explain the observed endogenous ABCC-type transport in Sf9 vesicles. Although further studies are needed to verify the role of SfABCC2 and SfABCC3 in Sf9 vesicles, the findings of this study highlight the need to carefully characterize background transport in Sf9 derived membrane vesicles to avoid false positive substrate findings for human ABC transporters studied with this overexpression system.
ATP 结合盒(ABC)家族的转运蛋白存在于所有生命领域。在人类中,几种 ABC 外排转运蛋白在药物处置和排泄中发挥作用。因此,已经开发了体外方法来研究这些转运蛋白对药物的底物和抑制剂特性。在囊泡转运测定中,使用来源于哺乳动物和昆虫来源的转运蛋白过表达细胞系的反向膜囊泡研究转运。与背景相比,昆虫细胞表达系统的表达更高,但与哺乳动物对应物相比,关于内源性转运,它们的特征描述并不完善。因此,该测定中这种转运的贡献可能被低估了。在这项研究中,使用人 ABC 转运蛋白的四种典型底物:5(6)-羧基-2',7'-二氯荧光素(CDCF)、雌二醇-17β-葡糖苷酸、雌酮硫酸盐和 N-甲基-奎尼定,来表征来源于 Spodoptera frugiperda 的 Sf9 细胞的膜囊泡中的内源性转运。用胆固醇装载囊泡观察到三种底物的 ATP 依赖性转运,这有时用于提高 Sf9 细胞中表达的人转运蛋白的活性。胆固醇对 CDCF 转运的影响最大,胆固醇装载的 Sf9 囊泡中的这种转运具有时间和浓度依赖性,K 值为 8.06±1.11μM。观察到的 CDCF 转运被人 ABCC 转运蛋白的已知抑制剂抑制,但分别被 ABCB1 和 ABCG2 抑制剂维拉帕米和 Ko143 抑制。基于序列分析,在 S. frugiperda 基因组中鉴定了两个候选 ABCC 型转运蛋白基因(SfABCC2 和 SfABCC3),作为解释 Sf9 囊泡中观察到的内源性 ABCC 型转运的假设。尽管需要进一步研究来验证 SfABCC2 和 SfABCC3 在 Sf9 囊泡中的作用,但这项研究的结果强调了需要仔细描述 Sf9 衍生的膜囊泡中的背景转运,以避免在使用这种过表达系统研究人 ABC 转运蛋白时出现假阳性底物发现。